Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04333745 · ClinicalTrials.gov registry record · NA

Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers

A NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
22
Enrollment target
2
Study locations

NCT04333745 is a NA study of Kidney Stone that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04333745, a NA study of Kidney Stone, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
2
Study locations

Study Summary

The primary goals of this study are to determine the contribution of dietary oxalate absorption, renal oxalate handling, and endogenous oxalate synthesis to urinary oxalate excretion in normal Body Mass Index (BMI) and obese calcium oxalate kidney stone formers.

Conditions Studied

Interventions

  • OTHER Controlled Diet
  • DIETARY_SUPPLEMENT Carbon-13 Oxalate and Sucralose Ingestion

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-09-01
Est. Completion 2026-12-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04333745

The ClinicalTrials.gov registry entry for NCT04333745 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (89% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which Controlled Diet is the first listed.

NCT04333745 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Texas.

Frequently Asked Questions

What is clinical trial NCT04333745 about?

NCT04333745 is a clinical study titled "Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers". The primary goals of this study are to determine the contribution of dietary oxalate absorption, renal oxalate handling, and endogenous oxalate synthesis to urinary oxalate excretion in normal Body Mass Index (BMI) and obese calcium oxalate kidney stone formers.

What is the current status of trial NCT04333745?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2021-09-01. Estimated completion is 2026-12-01.

What conditions does trial NCT04333745 study?

This clinical trial studies the following conditions: Kidney Stone.

What interventions are being tested in trial NCT04333745?

The interventions under investigation include: Controlled Diet (OTHER), Carbon-13 Oxalate and Sucralose Ingestion (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04333745?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04333745 being conducted?

This trial has 2 study locations across Alabama, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.